

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | mannose metabolic process (GO:0006013) | 4.38435653 |
| 2 | negative regulation of cell killing (GO:0031342) | 4.31796853 |
| 3 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.31796853 |
| 4 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.05244784 |
| 5 | neuron cell-cell adhesion (GO:0007158) | 4.02628269 |
| 6 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.96349065 |
| 7 | neuronal action potential propagation (GO:0019227) | 3.96285233 |
| 8 | presynaptic membrane assembly (GO:0097105) | 3.91014797 |
| 9 | protein localization to cilium (GO:0061512) | 3.89144204 |
| 10 | synaptic vesicle exocytosis (GO:0016079) | 3.85015294 |
| 11 | glutamate receptor signaling pathway (GO:0007215) | 3.73380365 |
| 12 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.67443085 |
| 13 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.66416876 |
| 14 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.62526047 |
| 15 | synaptic transmission, glutamatergic (GO:0035249) | 3.62124488 |
| 16 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.60126104 |
| 17 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.53206367 |
| 18 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.52229981 |
| 19 | positive thymic T cell selection (GO:0045059) | 3.49737508 |
| 20 | regulation of neuron projection regeneration (GO:0070570) | 3.49444176 |
| 21 | regulation of axon regeneration (GO:0048679) | 3.49444176 |
| 22 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.40983682 |
| 23 | postsynaptic membrane organization (GO:0001941) | 3.40055597 |
| 24 | chaperone-mediated protein transport (GO:0072321) | 3.39016261 |
| 25 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.37192493 |
| 26 | presynaptic membrane organization (GO:0097090) | 3.35515176 |
| 27 | neuron-neuron synaptic transmission (GO:0007270) | 3.32775591 |
| 28 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 3.30276765 |
| 29 | ATP hydrolysis coupled proton transport (GO:0015991) | 3.30276765 |
| 30 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.30124902 |
| 31 | phosphatidylglycerol biosynthetic process (GO:0006655) | 3.28212740 |
| 32 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.27449739 |
| 33 | vocalization behavior (GO:0071625) | 3.27334351 |
| 34 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.27330197 |
| 35 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.27140493 |
| 36 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.27082694 |
| 37 | immunoglobulin mediated immune response (GO:0016064) | 3.24680181 |
| 38 | protein localization to synapse (GO:0035418) | 3.23417413 |
| 39 | calcium ion-dependent exocytosis (GO:0017156) | 3.18290045 |
| 40 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.17599436 |
| 41 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.17321201 |
| 42 | transmission of nerve impulse (GO:0019226) | 3.16460874 |
| 43 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.15707360 |
| 44 | negative regulation of type 2 immune response (GO:0002829) | 3.15419831 |
| 45 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.14090570 |
| 46 | NADH dehydrogenase complex assembly (GO:0010257) | 3.14090570 |
| 47 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.14090570 |
| 48 | protein complex biogenesis (GO:0070271) | 3.09994748 |
| 49 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.09758655 |
| 50 | detection of bacterium (GO:0016045) | 3.09409959 |
| 51 | NIK/NF-kappaB signaling (GO:0038061) | 3.09113443 |
| 52 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.09009674 |
| 53 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.06232154 |
| 54 | gamma-aminobutyric acid transport (GO:0015812) | 3.06109634 |
| 55 | response to histamine (GO:0034776) | 3.05640913 |
| 56 | negative thymic T cell selection (GO:0045060) | 3.03047061 |
| 57 | positive regulation of inositol phosphate biosynthetic process (GO:0060732) | 3.03022379 |
| 58 | respiratory chain complex IV assembly (GO:0008535) | 3.00797437 |
| 59 | positive regulation by symbiont of host defense response (GO:0052509) | 3.00358446 |
| 60 | modulation by symbiont of host defense response (GO:0052031) | 3.00358446 |
| 61 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.00358446 |
| 62 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.00358446 |
| 63 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.00358446 |
| 64 | modulation by symbiont of host immune response (GO:0052553) | 3.00358446 |
| 65 | leukocyte aggregation (GO:0070486) | 2.98576957 |
| 66 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.98357772 |
| 67 | fucose catabolic process (GO:0019317) | 2.98263104 |
| 68 | L-fucose metabolic process (GO:0042354) | 2.98263104 |
| 69 | L-fucose catabolic process (GO:0042355) | 2.98263104 |
| 70 | acrosome reaction (GO:0007340) | 2.96989604 |
| 71 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 2.95172316 |
| 72 | detection of other organism (GO:0098543) | 2.94174847 |
| 73 | regulation of glutamate receptor signaling pathway (GO:1900449) | 2.94158559 |
| 74 | mannosylation (GO:0097502) | 2.94127106 |
| 75 | thymic T cell selection (GO:0045061) | 2.93190023 |
| 76 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.93130379 |
| 77 | neurotransmitter secretion (GO:0007269) | 2.92708489 |
| 78 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.91968700 |
| 79 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.91007128 |
| 80 | regulation of gamma-delta T cell activation (GO:0046643) | 2.90883646 |
| 81 | macrophage activation involved in immune response (GO:0002281) | 2.89939247 |
| 82 | positive regulation of membrane potential (GO:0045838) | 2.89193568 |
| 83 | regulation of vesicle fusion (GO:0031338) | 2.89050749 |
| 84 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.88503968 |
| 85 | ATP synthesis coupled proton transport (GO:0015986) | 2.88426842 |
| 86 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 2.88426842 |
| 87 | glutamate secretion (GO:0014047) | 2.87884428 |
| 88 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.86063515 |
| 89 | positive regulation of synapse assembly (GO:0051965) | 2.85570448 |
| 90 | transferrin transport (GO:0033572) | 2.84871317 |
| 91 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.83225904 |
| 92 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.82108760 |
| 93 | negative T cell selection (GO:0043383) | 2.81660298 |
| 94 | defense response to protozoan (GO:0042832) | 2.81493348 |
| 95 | neuromuscular process controlling posture (GO:0050884) | 2.81068257 |
| 96 | regulation of postsynaptic membrane potential (GO:0060078) | 2.80220408 |
| 97 | actin nucleation (GO:0045010) | 2.79812313 |
| 98 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 2.79123962 |
| 99 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.78055474 |
| 100 | activated T cell proliferation (GO:0050798) | 2.77732337 |
| 101 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.77185314 |
| 102 | platelet dense granule organization (GO:0060155) | 2.75587540 |
| 103 | T cell selection (GO:0045058) | 2.74935339 |
| 104 | response to muramyl dipeptide (GO:0032495) | 2.74297451 |
| 105 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.72923659 |
| 106 | startle response (GO:0001964) | 2.71810696 |
| 107 | neurotransmitter uptake (GO:0001504) | 2.71338478 |
| 108 | epithelial cilium movement (GO:0003351) | 2.71001376 |
| 109 | positive T cell selection (GO:0043368) | 2.70139905 |
| 110 | regulation of type 2 immune response (GO:0002828) | 2.68868564 |
| 111 | regulation of ARF GTPase activity (GO:0032312) | 2.68687515 |
| 112 | response to type I interferon (GO:0034340) | 2.68553581 |
| 113 | cellular response to type I interferon (GO:0071357) | 2.67847402 |
| 114 | type I interferon signaling pathway (GO:0060337) | 2.67847402 |
| 115 | respiratory electron transport chain (GO:0022904) | 2.67515884 |
| 116 | L-serine transport (GO:0015825) | 2.67147343 |
| 117 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.65999490 |
| 118 | proline transport (GO:0015824) | 2.64754533 |
| 119 | electron transport chain (GO:0022900) | 2.64387285 |
| 120 | negative regulation of dendrite morphogenesis (GO:0050774) | 2.64058069 |
| 121 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.63524158 |
| 122 | exploration behavior (GO:0035640) | 2.63522933 |
| 123 | neurotransmitter transport (GO:0006836) | 2.63467234 |
| 124 | long-term synaptic potentiation (GO:0060291) | 2.63051489 |
| 125 | adult walking behavior (GO:0007628) | 2.62962135 |
| 126 | regulation of synaptic vesicle transport (GO:1902803) | 2.62627767 |
| 127 | membrane depolarization (GO:0051899) | 2.61215450 |
| 128 | neuron recognition (GO:0008038) | 2.60761007 |
| 129 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.60532037 |
| 130 | serine transport (GO:0032329) | 2.59783955 |
| 131 | ferric iron transport (GO:0015682) | 2.58388349 |
| 132 | trivalent inorganic cation transport (GO:0072512) | 2.58388349 |
| 133 | serotonin metabolic process (GO:0042428) | 2.58057647 |
| 134 | neuronal action potential (GO:0019228) | 2.57864281 |
| 135 | regulation of inositol phosphate biosynthetic process (GO:0010919) | 2.57138263 |
| 136 | membrane depolarization during action potential (GO:0086010) | 2.56270304 |
| 137 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.56117898 |
| 138 | response to protozoan (GO:0001562) | 2.55589418 |
| 139 | positive regulation of type 2 immune response (GO:0002830) | 2.55502255 |
| 140 | germinal center formation (GO:0002467) | 2.55157622 |
| 141 | cytochrome complex assembly (GO:0017004) | 2.54753347 |
| 142 | tolerance induction (GO:0002507) | 2.54270029 |
| 143 | regulation of neurotransmitter levels (GO:0001505) | 2.52441175 |
| 144 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.51985429 |
| 145 | B cell receptor signaling pathway (GO:0050853) | 2.50958132 |
| 146 | pH reduction (GO:0045851) | 2.50407487 |
| 147 | locomotory exploration behavior (GO:0035641) | 2.50216558 |
| 148 | fucosylation (GO:0036065) | 2.50176009 |
| 149 | phagosome maturation (GO:0090382) | 2.48968672 |
| 150 | regulation of cilium movement (GO:0003352) | 2.48901444 |
| 151 | intracellular pH reduction (GO:0051452) | 2.48652590 |
| 152 | regulation of beta-amyloid formation (GO:1902003) | 2.48540589 |
| 153 | response to peptidoglycan (GO:0032494) | 2.48289707 |
| 154 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.47265705 |
| 155 | glycoside metabolic process (GO:0016137) | 2.46599242 |
| 156 | negative regulation of neurotransmitter transport (GO:0051589) | 2.45994856 |
| 157 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.44227829 |
| 158 | positive regulation of antigen processing and presentation (GO:0002579) | 2.41929391 |
| 159 | negative regulation of innate immune response (GO:0045824) | 2.41407739 |
| 160 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.41295307 |
| 161 | cellular response to interleukin-15 (GO:0071350) | 2.39182416 |
| 162 | regulation of antigen processing and presentation (GO:0002577) | 2.37856282 |
| 163 | neutrophil activation (GO:0042119) | 2.37462929 |
| 164 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.37005195 |
| 165 | neutrophil activation involved in immune response (GO:0002283) | 2.34883010 |
| 166 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.31910226 |
| 167 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.31910226 |
| 168 | establishment of mitochondrion localization (GO:0051654) | 2.30916314 |
| 169 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.29874764 |
| 170 | response to interleukin-15 (GO:0070672) | 2.29468501 |
| 171 | detection of external biotic stimulus (GO:0098581) | 2.27039620 |
| 172 | negative regulation of alpha-beta T cell activation (GO:0046636) | 2.25078466 |
| 173 | regulation of ARF protein signal transduction (GO:0032012) | 2.24743053 |
| 174 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.24624377 |
| 175 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.24624377 |
| 176 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.23826555 |
| 177 | positive regulation of Rap GTPase activity (GO:0032854) | 2.22602498 |
| 178 | positive regulation of CREB transcription factor activity (GO:0032793) | 2.20227311 |
| 179 | regulation of hydrogen peroxide metabolic process (GO:0010310) | 2.19567208 |
| 180 | positive regulation of histone deacetylation (GO:0031065) | 2.17194559 |
| 181 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.17075467 |
| 182 | negative regulation of T cell mediated immunity (GO:0002710) | 2.17041014 |
| 183 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.16343951 |
| 184 | granulocyte activation (GO:0036230) | 2.15295504 |
| 185 | regulation of germinal center formation (GO:0002634) | 2.14650432 |
| 186 | regulation of B cell differentiation (GO:0045577) | 2.14507625 |
| 187 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 2.14126824 |
| 188 | regulation of mast cell degranulation (GO:0043304) | 2.13215285 |
| 189 | mitochondrion degradation (GO:0000422) | 2.10892578 |
| 190 | negative regulation of interleukin-6 production (GO:0032715) | 2.09680862 |
| 191 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.08984799 |
| 192 | neutrophil mediated immunity (GO:0002446) | 2.08419457 |
| 193 | phagocytosis (GO:0006909) | 2.07689352 |
| 194 | respiratory burst (GO:0045730) | 2.07684239 |
| 195 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.06320654 |
| 196 | response to host immune response (GO:0052572) | 2.06320654 |
| 197 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.05651488 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.43047555 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 4.70099355 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.70177677 |
| 4 | TAF15_26573619_Chip-Seq_HEK293_Human | 3.28370857 |
| 5 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 3.26963638 |
| 6 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.93931352 |
| 7 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.87133519 |
| 8 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.60372878 |
| 9 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.53726363 |
| 10 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.53131058 |
| 11 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.46003630 |
| 12 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.38840374 |
| 13 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.38080696 |
| 14 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.35842213 |
| 15 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.27928582 |
| 16 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.27593999 |
| 17 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.27188735 |
| 18 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 2.25507278 |
| 19 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.23249920 |
| 20 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.21652498 |
| 21 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.19616218 |
| 22 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.17258440 |
| 23 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.15703962 |
| 24 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 2.07867330 |
| 25 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.03730348 |
| 26 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.03108013 |
| 27 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.01978024 |
| 28 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.01292064 |
| 29 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.98884158 |
| 30 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.98827840 |
| 31 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.97656332 |
| 32 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.97005703 |
| 33 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.95749700 |
| 34 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.95470196 |
| 35 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.93056155 |
| 36 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.92679576 |
| 37 | P68_20966046_ChIP-Seq_HELA_Human | 1.91739938 |
| 38 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.88890325 |
| 39 | P300_19829295_ChIP-Seq_ESCs_Human | 1.87394917 |
| 40 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.85929770 |
| 41 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.85629600 |
| 42 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.83987444 |
| 43 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.81617715 |
| 44 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.79992145 |
| 45 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.77007535 |
| 46 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.76845634 |
| 47 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.76845634 |
| 48 | FUS_26573619_Chip-Seq_HEK293_Human | 1.75290279 |
| 49 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.74493390 |
| 50 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.73870157 |
| 51 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.72720932 |
| 52 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.71580653 |
| 53 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.68451744 |
| 54 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.67712372 |
| 55 | MAF_26560356_Chip-Seq_TH2_Human | 1.65890398 |
| 56 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.65179676 |
| 57 | UTX_26944678_Chip-Seq_JUKART_Human | 1.63224291 |
| 58 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.61890038 |
| 59 | * GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.61195088 |
| 60 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.61120287 |
| 61 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.60996274 |
| 62 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.60468649 |
| 63 | MYC_22102868_ChIP-Seq_BL_Human | 1.58991074 |
| 64 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.58989484 |
| 65 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.58395212 |
| 66 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.58097731 |
| 67 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.56229408 |
| 68 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.55392816 |
| 69 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.54415234 |
| 70 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.54104781 |
| 71 | MAF_26560356_Chip-Seq_TH1_Human | 1.53951842 |
| 72 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.53860922 |
| 73 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.53335182 |
| 74 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.52735959 |
| 75 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.51352986 |
| 76 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.50515480 |
| 77 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.50052082 |
| 78 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.47428061 |
| 79 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.47113658 |
| 80 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.46345787 |
| 81 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.45842908 |
| 82 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.44689020 |
| 83 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.44598750 |
| 84 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.43611713 |
| 85 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.43124918 |
| 86 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.42489447 |
| 87 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.42338785 |
| 88 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.41953293 |
| 89 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.41336801 |
| 90 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.41118645 |
| 91 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.41025247 |
| 92 | KDM2B_26808549_Chip-Seq_K562_Human | 1.40737596 |
| 93 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.40085637 |
| 94 | AR_25329375_ChIP-Seq_VCAP_Human | 1.40050320 |
| 95 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.38175435 |
| 96 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.37923812 |
| 97 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.37700083 |
| 98 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.37237777 |
| 99 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.36890879 |
| 100 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.36677931 |
| 101 | EWS_26573619_Chip-Seq_HEK293_Human | 1.36659297 |
| 102 | SPI1_23127762_ChIP-Seq_K562_Human | 1.36106264 |
| 103 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.35396334 |
| 104 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.34662470 |
| 105 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.33187640 |
| 106 | VDR_22108803_ChIP-Seq_LS180_Human | 1.32823677 |
| 107 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.32545855 |
| 108 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.31002515 |
| 109 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.30779665 |
| 110 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.28647521 |
| 111 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.27754788 |
| 112 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.26861693 |
| 113 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.25062024 |
| 114 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.24423352 |
| 115 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.23830929 |
| 116 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.23758431 |
| 117 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.22945778 |
| 118 | OCT4_19829295_ChIP-Seq_ESCs_Human | 1.22415699 |
| 119 | SA1_27219007_Chip-Seq_Bcells_Human | 1.22295748 |
| 120 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.22050278 |
| 121 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.21373433 |
| 122 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.21140187 |
| 123 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.20722502 |
| 124 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.20473111 |
| 125 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.19413053 |
| 126 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.19179068 |
| 127 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.19036720 |
| 128 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.18873461 |
| 129 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.18177053 |
| 130 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.17837753 |
| 131 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.15479406 |
| 132 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.14873543 |
| 133 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.14613969 |
| 134 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.14509906 |
| 135 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.14497083 |
| 136 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.14069762 |
| 137 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.13973365 |
| 138 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.13782140 |
| 139 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.13231216 |
| 140 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.12671211 |
| 141 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.11341666 |
| 142 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.11063013 |
| 143 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.10456352 |
| 144 | KDM2B_26808549_Chip-Seq_REH_Human | 1.09146076 |
| 145 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 1.08988101 |
| 146 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.08888818 |
| 147 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.08592407 |
| 148 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.08419428 |
| 149 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.08397538 |
| 150 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.08152306 |
| 151 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.08014732 |
| 152 | TCF4_23295773_ChIP-Seq_U87_Human | 1.05809798 |
| 153 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.05458832 |
| 154 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.05148194 |
| 155 | * TP63_22573176_ChIP-Seq_HFKS_Human | 1.05056631 |
| 156 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.04668520 |
| 157 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.04582925 |
| 158 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.03909079 |
| 159 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.03301489 |
| 160 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.03134778 |
| 161 | * JUN_21703547_ChIP-Seq_K562_Human | 1.02451134 |
| 162 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.02176383 |
| 163 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.02090695 |
| 164 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.02041106 |
| 165 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.01681336 |
| 166 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.01194661 |
| 167 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.01194661 |
| 168 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.00924798 |
| 169 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.00275731 |
| 170 | P300_27268052_Chip-Seq_Bcells_Human | 1.00180040 |
| 171 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.99806499 |
| 172 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.99680557 |
| 173 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.99362188 |
| 174 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.98502898 |
| 175 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.98296699 |
| 176 | ERA_21632823_ChIP-Seq_H3396_Human | 0.98033959 |
| 177 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.97413200 |
| 178 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.97277955 |
| 179 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.94867951 |
| 180 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.94582939 |
| 181 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.94582939 |
| 182 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.94201582 |
| 183 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.94179489 |
| 184 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.94031380 |
| 185 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 0.91811560 |
| 186 | P300_18555785_Chip-Seq_ESCs_Mouse | 0.90932713 |
| 187 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.90799063 |
| 188 | STAT3_23295773_ChIP-Seq_U87_Human | 0.89900221 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003880_abnormal_central_pattern | 4.84217910 |
| 2 | MP0004859_abnormal_synaptic_plasticity | 4.29228309 |
| 3 | MP0002736_abnormal_nociception_after | 3.42109393 |
| 4 | MP0003436_decreased_susceptibility_to | 3.42095628 |
| 5 | MP0001968_abnormal_touch/_nociception | 3.34184681 |
| 6 | MP0003635_abnormal_synaptic_transmissio | 3.15267104 |
| 7 | MP0003724_increased_susceptibility_to | 3.12891037 |
| 8 | MP0002735_abnormal_chemical_nociception | 3.01834029 |
| 9 | MP0009745_abnormal_behavioral_response | 2.94132375 |
| 10 | MP0009046_muscle_twitch | 2.85533727 |
| 11 | MP0002064_seizures | 2.76220919 |
| 12 | MP0002272_abnormal_nervous_system | 2.48794133 |
| 13 | MP0001835_abnormal_antigen_presentation | 2.47529071 |
| 14 | MP0002572_abnormal_emotion/affect_behav | 2.41309025 |
| 15 | MP0003303_peritoneal_inflammation | 2.40298685 |
| 16 | MP0005671_abnormal_response_to | 2.39388372 |
| 17 | MP0006276_abnormal_autonomic_nervous | 2.35319770 |
| 18 | MP0001986_abnormal_taste_sensitivity | 2.31146545 |
| 19 | MP0002063_abnormal_learning/memory/cond | 2.29496309 |
| 20 | MP0005058_abnormal_lysosome_morphology | 2.28970062 |
| 21 | MP0001790_abnormal_immune_system | 2.25847015 |
| 22 | MP0005387_immune_system_phenotype | 2.25847015 |
| 23 | MP0001501_abnormal_sleep_pattern | 2.25290026 |
| 24 | MP0005171_absent_coat_pigmentation | 2.24160209 |
| 25 | MP0005000_abnormal_immune_tolerance | 2.24012577 |
| 26 | MP0001800_abnormal_humoral_immune | 2.20827661 |
| 27 | MP0005025_abnormal_response_to | 2.17480854 |
| 28 | MP0005410_abnormal_fertilization | 2.15690524 |
| 29 | MP0001905_abnormal_dopamine_level | 2.13942141 |
| 30 | MP0004270_analgesia | 2.11706207 |
| 31 | MP0002419_abnormal_innate_immunity | 2.04659782 |
| 32 | MP0002734_abnormal_mechanical_nocicepti | 2.02820063 |
| 33 | MP0009278_abnormal_bone_marrow | 1.99969766 |
| 34 | MP0001188_hyperpigmentation | 1.97016321 |
| 35 | MP0002733_abnormal_thermal_nociception | 1.96200089 |
| 36 | MP0003136_yellow_coat_color | 1.96117338 |
| 37 | MP0002723_abnormal_immune_serum | 1.95460011 |
| 38 | MP0002067_abnormal_sensory_capabilities | 1.95326729 |
| 39 | MP0001529_abnormal_vocalization | 1.94513787 |
| 40 | MP0001970_abnormal_pain_threshold | 1.92566913 |
| 41 | MP0000685_abnormal_immune_system | 1.90054169 |
| 42 | MP0002876_abnormal_thyroid_physiology | 1.88621550 |
| 43 | MP0001486_abnormal_startle_reflex | 1.85583968 |
| 44 | MP0001440_abnormal_grooming_behavior | 1.83882871 |
| 45 | MP0009785_altered_susceptibility_to | 1.82546759 |
| 46 | MP0002420_abnormal_adaptive_immunity | 1.79707771 |
| 47 | MP0002452_abnormal_antigen_presenting | 1.78481618 |
| 48 | MP0001819_abnormal_immune_cell | 1.78462447 |
| 49 | MP0005423_abnormal_somatic_nervous | 1.77017844 |
| 50 | MP0004142_abnormal_muscle_tone | 1.71911772 |
| 51 | MP0001533_abnormal_skeleton_physiology | 1.70043190 |
| 52 | MP0002653_abnormal_ependyma_morphology | 1.69590573 |
| 53 | MP0001984_abnormal_olfaction | 1.62110879 |
| 54 | MP0008569_lethality_at_weaning | 1.60490449 |
| 55 | MP0001502_abnormal_circadian_rhythm | 1.58620576 |
| 56 | MP0006082_CNS_inflammation | 1.54824505 |
| 57 | MP0005379_endocrine/exocrine_gland_phen | 1.54114741 |
| 58 | MP0002148_abnormal_hypersensitivity_rea | 1.53891710 |
| 59 | MP0002557_abnormal_social/conspecific_i | 1.53775860 |
| 60 | MP0003763_abnormal_thymus_physiology | 1.45734689 |
| 61 | MP0000465_gastrointestinal_hemorrhage | 1.42634871 |
| 62 | MP0004510_myositis | 1.41791693 |
| 63 | MP0002822_catalepsy | 1.38186147 |
| 64 | MP0003329_amyloid_beta_deposits | 1.37425861 |
| 65 | MP0002405_respiratory_system_inflammati | 1.37138638 |
| 66 | MP0005174_abnormal_tail_pigmentation | 1.34972964 |
| 67 | MP0004147_increased_porphyrin_level | 1.34898456 |
| 68 | MP0002638_abnormal_pupillary_reflex | 1.33837746 |
| 69 | MP0010155_abnormal_intestine_physiology | 1.33647665 |
| 70 | MP0000372_irregular_coat_pigmentation | 1.33050883 |
| 71 | MP0000604_amyloidosis | 1.31332398 |
| 72 | MP0000716_abnormal_immune_system | 1.31042005 |
| 73 | MP0002138_abnormal_hepatobiliary_system | 1.29468415 |
| 74 | MP0002933_joint_inflammation | 1.27569628 |
| 75 | MP0009780_abnormal_chondrocyte_physiolo | 1.26857469 |
| 76 | MP0000015_abnormal_ear_pigmentation | 1.26735198 |
| 77 | MP0005386_behavior/neurological_phenoty | 1.23484958 |
| 78 | MP0004924_abnormal_behavior | 1.23484958 |
| 79 | MP0003866_abnormal_defecation | 1.23370292 |
| 80 | MP0003075_altered_response_to | 1.23345544 |
| 81 | MP0003191_abnormal_cellular_cholesterol | 1.21923009 |
| 82 | MP0003183_abnormal_peptide_metabolism | 1.21752468 |
| 83 | MP0001845_abnormal_inflammatory_respons | 1.21664515 |
| 84 | MP0004947_skin_inflammation | 1.19776338 |
| 85 | MP0009379_abnormal_foot_pigmentation | 1.19068876 |
| 86 | MP0005646_abnormal_pituitary_gland | 1.18540649 |
| 87 | MP0005645_abnormal_hypothalamus_physiol | 1.17497551 |
| 88 | MP0002398_abnormal_bone_marrow | 1.16892580 |
| 89 | MP0008260_abnormal_autophagy | 1.15807853 |
| 90 | MP0005409_darkened_coat_color | 1.14534653 |
| 91 | MP0004381_abnormal_hair_follicle | 1.13929687 |
| 92 | MP0002009_preneoplasia | 1.11107602 |
| 93 | MP0003633_abnormal_nervous_system | 1.11002878 |
| 94 | MP0001873_stomach_inflammation | 1.10818315 |
| 95 | MP0000920_abnormal_myelination | 1.10670746 |
| 96 | MP0009764_decreased_sensitivity_to | 1.10630227 |
| 97 | MP0002066_abnormal_motor_capabilities/c | 1.09871708 |
| 98 | MP0001664_abnormal_digestion | 1.08937712 |
| 99 | MP0003122_maternal_imprinting | 1.07069103 |
| 100 | MP0002229_neurodegeneration | 1.05666217 |
| 101 | MP0008469_abnormal_protein_level | 1.05160552 |
| 102 | MP0005464_abnormal_platelet_physiology | 1.03636738 |
| 103 | MP0002184_abnormal_innervation | 1.02340130 |
| 104 | MP0003631_nervous_system_phenotype | 1.01767579 |
| 105 | MP0001963_abnormal_hearing_physiology | 1.01429935 |
| 106 | MP0002882_abnormal_neuron_morphology | 1.00732594 |
| 107 | MP0009840_abnormal_foam_cell | 0.99207116 |
| 108 | MP0002163_abnormal_gland_morphology | 0.98635185 |
| 109 | MP0000689_abnormal_spleen_morphology | 0.98184560 |
| 110 | MP0004858_abnormal_nervous_system | 0.97804167 |
| 111 | MP0005397_hematopoietic_system_phenotyp | 0.97682294 |
| 112 | MP0001545_abnormal_hematopoietic_system | 0.97682294 |
| 113 | MP0002837_dystrophic_cardiac_calcinosis | 0.97390915 |
| 114 | MP0003172_abnormal_lysosome_physiology | 0.93352520 |
| 115 | MP0000955_abnormal_spinal_cord | 0.92975442 |
| 116 | MP0003300_gastrointestinal_ulcer | 0.92558928 |
| 117 | MP0000778_abnormal_nervous_system | 0.92204067 |
| 118 | MP0004215_abnormal_myocardial_fiber | 0.91560556 |
| 119 | MP0002429_abnormal_blood_cell | 0.91085645 |
| 120 | MP0003690_abnormal_glial_cell | 0.89712595 |
| 121 | MP0002909_abnormal_adrenal_gland | 0.89533927 |
| 122 | MP0003879_abnormal_hair_cell | 0.87061859 |
| 123 | MP0001765_abnormal_ion_homeostasis | 0.86988062 |
| 124 | MP0005551_abnormal_eye_electrophysiolog | 0.86512242 |
| 125 | MP0005167_abnormal_blood-brain_barrier | 0.86475200 |
| 126 | MP0002722_abnormal_immune_system | 0.86238273 |
| 127 | MP0005166_decreased_susceptibility_to | 0.85472420 |
| 128 | MP0003698_abnormal_male_reproductive | 0.85043994 |
| 129 | MP0004130_abnormal_muscle_cell | 0.84805394 |
| 130 | MP0005310_abnormal_salivary_gland | 0.84447099 |
| 131 | MP0005075_abnormal_melanosome_morpholog | 0.84390558 |
| 132 | MP0004811_abnormal_neuron_physiology | 0.83593681 |
| 133 | MP0002095_abnormal_skin_pigmentation | 0.83301509 |
| 134 | MP0008872_abnormal_physiological_respon | 0.83021264 |
| 135 | MP0008874_decreased_physiological_sensi | 0.82736231 |
| 136 | MP0000681_abnormal_thyroid_gland | 0.80700724 |
| 137 | MP0005390_skeleton_phenotype | 0.78696973 |
| 138 | MP0005535_abnormal_body_temperature | 0.78537971 |
| 139 | MP0006035_abnormal_mitochondrial_morpho | 0.78447218 |
| 140 | MP0003632_abnormal_nervous_system | 0.78224357 |
| 141 | MP0004484_altered_response_of | 0.77912545 |
| 142 | MP0004885_abnormal_endolymph | 0.76857443 |
| 143 | MP0003634_abnormal_glial_cell | 0.76807163 |
| 144 | MP0002998_abnormal_bone_remodeling | 0.76047877 |
| 145 | MP0009697_abnormal_copulation | 0.75290978 |
| 146 | MP0009333_abnormal_splenocyte_physiolog | 0.74621254 |
| 147 | MP0005595_abnormal_vascular_smooth | 0.73353775 |
| 148 | MP0001958_emphysema | 0.71537889 |
| 149 | MP0002132_abnormal_respiratory_system | 0.71125388 |
| 150 | MP0004145_abnormal_muscle_electrophysio | 0.70895179 |
| 151 | MP0001485_abnormal_pinna_reflex | 0.70421127 |
| 152 | MP0000678_abnormal_parathyroid_gland | 0.68912758 |
| 153 | MP0000230_abnormal_systemic_arterial | 0.68778414 |
| 154 | MP0009384_cardiac_valve_regurgitation | 0.68143607 |
| 155 | MP0005360_urolithiasis | 0.67064054 |
| 156 | MP0005365_abnormal_bile_salt | 0.66415557 |
| 157 | MP0000013_abnormal_adipose_tissue | 0.65894303 |
| 158 | MP0004883_abnormal_blood_vessel | 0.65685287 |
| 159 | MP0008004_abnormal_stomach_pH | 0.65174610 |
| 160 | MP0002069_abnormal_eating/drinking_beha | 0.64340560 |
| 161 | MP0004742_abnormal_vestibular_system | 0.63681397 |
| 162 | MP0004043_abnormal_pH_regulation | 0.63188889 |
| 163 | MP0010386_abnormal_urinary_bladder | 0.62717715 |
| 164 | MP0003787_abnormal_imprinting | 0.62379646 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 6.41034345 |
| 2 | Eczematoid dermatitis (HP:0000976) | 4.44683030 |
| 3 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.34578480 |
| 4 | Atonic seizures (HP:0010819) | 4.17335692 |
| 5 | Myositis (HP:0100614) | 3.85926285 |
| 6 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 3.84595189 |
| 7 | Absent/shortened dynein arms (HP:0200106) | 3.84595189 |
| 8 | Severe visual impairment (HP:0001141) | 3.72992672 |
| 9 | Myokymia (HP:0002411) | 3.68264240 |
| 10 | Epileptic encephalopathy (HP:0200134) | 3.58636537 |
| 11 | Stomatitis (HP:0010280) | 3.43205979 |
| 12 | Hepatocellular necrosis (HP:0001404) | 3.42136283 |
| 13 | Visual hallucinations (HP:0002367) | 3.41905737 |
| 14 | Hypothermia (HP:0002045) | 3.39728155 |
| 15 | J-shaped sella turcica (HP:0002680) | 3.39406525 |
| 16 | Febrile seizures (HP:0002373) | 3.33453712 |
| 17 | Agammaglobulinemia (HP:0004432) | 3.28991214 |
| 18 | Mitochondrial inheritance (HP:0001427) | 3.28671675 |
| 19 | Recurrent abscess formation (HP:0002722) | 3.26813538 |
| 20 | Abnormal hair whorl (HP:0010721) | 3.24318308 |
| 21 | Dysostosis multiplex (HP:0000943) | 3.22067170 |
| 22 | Focal seizures (HP:0007359) | 3.21724116 |
| 23 | Abnormality of macrophages (HP:0004311) | 3.21526005 |
| 24 | Acute necrotizing encephalopathy (HP:0006965) | 3.16746499 |
| 25 | Ankle clonus (HP:0011448) | 3.15599743 |
| 26 | Recurrent fungal infections (HP:0002841) | 3.14673811 |
| 27 | Obstructive sleep apnea (HP:0002870) | 3.13478861 |
| 28 | Recurrent bacterial skin infections (HP:0005406) | 3.13046581 |
| 29 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.06648200 |
| 30 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.06648200 |
| 31 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.06648200 |
| 32 | Mediastinal lymphadenopathy (HP:0100721) | 2.97640514 |
| 33 | Orchitis (HP:0100796) | 2.96524697 |
| 34 | Obstructive lung disease (HP:0006536) | 2.96380892 |
| 35 | Chronic obstructive pulmonary disease (HP:0006510) | 2.96380892 |
| 36 | Meningitis (HP:0001287) | 2.95518586 |
| 37 | Increased IgE level (HP:0003212) | 2.94662627 |
| 38 | Gastrointestinal inflammation (HP:0004386) | 2.91495806 |
| 39 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.88651177 |
| 40 | Hyperventilation (HP:0002883) | 2.88358329 |
| 41 | Inflammation of the large intestine (HP:0002037) | 2.84520529 |
| 42 | Cellulitis (HP:0100658) | 2.84305183 |
| 43 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.83037203 |
| 44 | Mucopolysacchariduria (HP:0008155) | 2.83037203 |
| 45 | Generalized aminoaciduria (HP:0002909) | 2.79664238 |
| 46 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.77798742 |
| 47 | Dialeptic seizures (HP:0011146) | 2.77335306 |
| 48 | Colitis (HP:0002583) | 2.76410920 |
| 49 | Medial flaring of the eyebrow (HP:0010747) | 2.75081848 |
| 50 | Optic neuritis (HP:0100653) | 2.75044845 |
| 51 | Retrobulbar optic neuritis (HP:0100654) | 2.75044845 |
| 52 | Progressive macrocephaly (HP:0004481) | 2.74993865 |
| 53 | Increased CSF lactate (HP:0002490) | 2.72087433 |
| 54 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.71039813 |
| 55 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.71039813 |
| 56 | Panhypogammaglobulinemia (HP:0003139) | 2.70522837 |
| 57 | Absence seizures (HP:0002121) | 2.69315442 |
| 58 | Papilledema (HP:0001085) | 2.66518671 |
| 59 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 2.59865910 |
| 60 | Hepatic necrosis (HP:0002605) | 2.59060587 |
| 61 | Vasculitis (HP:0002633) | 2.57487080 |
| 62 | Gait imbalance (HP:0002141) | 2.55659212 |
| 63 | Flat occiput (HP:0005469) | 2.54380852 |
| 64 | Renal Fanconi syndrome (HP:0001994) | 2.52572228 |
| 65 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.50263281 |
| 66 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.48645915 |
| 67 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.48645915 |
| 68 | Abnormality of glycolipid metabolism (HP:0010969) | 2.48645915 |
| 69 | Congenital primary aphakia (HP:0007707) | 2.46980157 |
| 70 | Pustule (HP:0200039) | 2.46761571 |
| 71 | Progressive cerebellar ataxia (HP:0002073) | 2.44178387 |
| 72 | Nephronophthisis (HP:0000090) | 2.43694419 |
| 73 | Progressive inability to walk (HP:0002505) | 2.43366526 |
| 74 | Acute encephalopathy (HP:0006846) | 2.41020420 |
| 75 | Nonprogressive disorder (HP:0003680) | 2.40765050 |
| 76 | Nephrogenic diabetes insipidus (HP:0009806) | 2.40126998 |
| 77 | Polyphagia (HP:0002591) | 2.39624778 |
| 78 | Increased hepatocellular lipid droplets (HP:0006565) | 2.38304492 |
| 79 | Generalized tonic-clonic seizures (HP:0002069) | 2.37181194 |
| 80 | Recurrent cutaneous fungal infections (HP:0011370) | 2.36756231 |
| 81 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.36756231 |
| 82 | Prolonged bleeding time (HP:0003010) | 2.35677104 |
| 83 | Abnormality of renal resorption (HP:0011038) | 2.34765652 |
| 84 | Clumsiness (HP:0002312) | 2.33809959 |
| 85 | Gastrointestinal infarctions (HP:0005244) | 2.33713292 |
| 86 | Broad-based gait (HP:0002136) | 2.33033712 |
| 87 | Gaze-evoked nystagmus (HP:0000640) | 2.33001402 |
| 88 | Stridor (HP:0010307) | 2.32566724 |
| 89 | Pulmonary infiltrates (HP:0002113) | 2.31431946 |
| 90 | Gingivitis (HP:0000230) | 2.29940451 |
| 91 | Encephalitis (HP:0002383) | 2.29785923 |
| 92 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.28440956 |
| 93 | Mutism (HP:0002300) | 2.27738117 |
| 94 | Abnormal drinking behavior (HP:0030082) | 2.27051465 |
| 95 | Polydipsia (HP:0001959) | 2.27051465 |
| 96 | Gonadotropin excess (HP:0000837) | 2.24469146 |
| 97 | Poor suck (HP:0002033) | 2.23101280 |
| 98 | Type I transferrin isoform profile (HP:0003642) | 2.21654900 |
| 99 | Abnormal ciliary motility (HP:0012262) | 2.21501728 |
| 100 | Gastrointestinal stroma tumor (HP:0100723) | 2.21159557 |
| 101 | Neuronal loss in central nervous system (HP:0002529) | 2.20617226 |
| 102 | Loss of speech (HP:0002371) | 2.20470360 |
| 103 | Neurofibrillary tangles (HP:0002185) | 2.19836825 |
| 104 | Abnormal eating behavior (HP:0100738) | 2.19803856 |
| 105 | Hemoptysis (HP:0002105) | 2.19740410 |
| 106 | Pancreatic fibrosis (HP:0100732) | 2.19301500 |
| 107 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.17758472 |
| 108 | Joint stiffness (HP:0001387) | 2.17115919 |
| 109 | Recurrent skin infections (HP:0001581) | 2.17050649 |
| 110 | Progressive neurologic deterioration (HP:0002344) | 2.16585526 |
| 111 | Abnormal respiratory motile cilium physiology (HP:0012261) | 2.15732247 |
| 112 | Inability to walk (HP:0002540) | 2.15089698 |
| 113 | Abnormality of the columella (HP:0009929) | 2.14644694 |
| 114 | Abnormality of alanine metabolism (HP:0010916) | 2.13155488 |
| 115 | Hyperalaninemia (HP:0003348) | 2.13155488 |
| 116 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.13155488 |
| 117 | Systemic lupus erythematosus (HP:0002725) | 2.12951904 |
| 118 | Purpura (HP:0000979) | 2.11842297 |
| 119 | Lipid accumulation in hepatocytes (HP:0006561) | 2.10209761 |
| 120 | Abnormal protein glycosylation (HP:0012346) | 2.10001351 |
| 121 | Abnormal glycosylation (HP:0012345) | 2.10001351 |
| 122 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.10001351 |
| 123 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.10001351 |
| 124 | True hermaphroditism (HP:0010459) | 2.09924076 |
| 125 | Amblyopia (HP:0000646) | 2.09413750 |
| 126 | Chest pain (HP:0100749) | 2.09061402 |
| 127 | Neuroendocrine neoplasm (HP:0100634) | 2.09025983 |
| 128 | Recurrent sinusitis (HP:0011108) | 2.08575518 |
| 129 | Truncal ataxia (HP:0002078) | 2.08520388 |
| 130 | Diplopia (HP:0000651) | 2.08153742 |
| 131 | Abnormality of binocular vision (HP:0011514) | 2.08153742 |
| 132 | Hypergammaglobulinemia (HP:0010702) | 2.06922192 |
| 133 | Molar tooth sign on MRI (HP:0002419) | 2.05610633 |
| 134 | Abnormality of midbrain morphology (HP:0002418) | 2.05610633 |
| 135 | Methylmalonic acidemia (HP:0002912) | 2.04559210 |
| 136 | Cerebral palsy (HP:0100021) | 2.03756425 |
| 137 | Episodic fever (HP:0001954) | 2.03753301 |
| 138 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 2.00506530 |
| 139 | Petechiae (HP:0000967) | 2.00374327 |
| 140 | Patchy hypopigmentation of hair (HP:0011365) | 1.99889076 |
| 141 | Supranuclear gaze palsy (HP:0000605) | 1.99617307 |
| 142 | Interstitial pulmonary disease (HP:0006530) | 1.98872055 |
| 143 | Papilloma (HP:0012740) | 1.98771957 |
| 144 | Verrucae (HP:0200043) | 1.98771957 |
| 145 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.98246971 |
| 146 | Emphysema (HP:0002097) | 1.97911311 |
| 147 | Lactic acidosis (HP:0003128) | 1.96598279 |
| 148 | Spontaneous hematomas (HP:0007420) | 1.94131049 |
| 149 | Restrictive lung disease (HP:0002091) | 1.93383224 |
| 150 | White forelock (HP:0002211) | 1.92687261 |
| 151 | Respiratory difficulties (HP:0002880) | 1.92569602 |
| 152 | Easy fatigability (HP:0003388) | 1.92434137 |
| 153 | Amyloidosis (HP:0011034) | 1.91945302 |
| 154 | Autoamputation (HP:0001218) | 1.90990981 |
| 155 | Sepsis (HP:0100806) | 1.90396832 |
| 156 | Retinal dysplasia (HP:0007973) | 1.90329546 |
| 157 | Increased cerebral lipofuscin (HP:0011813) | 1.90287830 |
| 158 | Microvesicular hepatic steatosis (HP:0001414) | 1.90230439 |
| 159 | Esotropia (HP:0000565) | 1.86962394 |
| 160 | Hypoproteinemia (HP:0003075) | 1.86587184 |
| 161 | Neurodegeneration (HP:0002180) | 1.86286220 |
| 162 | Spinal canal stenosis (HP:0003416) | 1.85894378 |
| 163 | Poor coordination (HP:0002370) | 1.85802483 |
| 164 | Hemiparesis (HP:0001269) | 1.84870204 |
| 165 | Optic disc pallor (HP:0000543) | 1.84671221 |
| 166 | Hemorrhage of the eye (HP:0011885) | 1.84414176 |
| 167 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.84355267 |
| 168 | Recurrent viral infections (HP:0004429) | 1.83721099 |
| 169 | Epistaxis (HP:0000421) | 1.83623964 |
| 170 | Vaginal atresia (HP:0000148) | 1.83389140 |
| 171 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.82227349 |
| 172 | Leukocytosis (HP:0001974) | 1.81833465 |
| 173 | Genital tract atresia (HP:0001827) | 1.81503663 |
| 174 | Absent speech (HP:0001344) | 1.81412422 |
| 175 | Dysmetria (HP:0001310) | 1.81358864 |
| 176 | Hypomagnesemia (HP:0002917) | 1.81271777 |
| 177 | Urticaria (HP:0001025) | 1.81158259 |
| 178 | Methylmalonic aciduria (HP:0012120) | 1.80097920 |
| 179 | Polyuria (HP:0000103) | 1.80011442 |
| 180 | Increased intramyocellular lipid droplets (HP:0012240) | 1.79101833 |
| 181 | Reduced antithrombin III activity (HP:0001976) | 1.78446124 |
| 182 | Blue irides (HP:0000635) | 1.78384820 |
| 183 | Emotional lability (HP:0000712) | 1.78096650 |
| 184 | Lymphopenia (HP:0001888) | 1.77922772 |
| 185 | Global brain atrophy (HP:0002283) | 1.77135723 |
| 186 | Broad face (HP:0000283) | 1.76939355 |
| 187 | Hypertensive crisis (HP:0100735) | 1.75647219 |
| 188 | Granulocytopenia (HP:0001913) | 1.75023648 |
| 189 | Abnormality of the nasal mucosa (HP:0000433) | 1.74836743 |
| 190 | Growth hormone excess (HP:0000845) | 1.74617908 |
| 191 | Cervical subluxation (HP:0003308) | 1.73649393 |
| 192 | Progressive microcephaly (HP:0000253) | 1.70155909 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K12 | 3.95124678 |
| 2 | TNIK | 3.68893647 |
| 3 | CASK | 3.64539884 |
| 4 | EPHA4 | 3.45609061 |
| 5 | NTRK3 | 3.36794953 |
| 6 | MAP4K1 | 3.30704672 |
| 7 | MAP2K7 | 3.01977087 |
| 8 | ERN1 | 2.82109202 |
| 9 | CDK19 | 2.75281425 |
| 10 | MAP3K13 | 2.43204745 |
| 11 | MAP3K11 | 2.23234979 |
| 12 | MUSK | 2.17904366 |
| 13 | MAP3K4 | 2.13757316 |
| 14 | PRKD3 | 2.08967815 |
| 15 | GRK6 | 2.06387620 |
| 16 | BLK | 1.98174831 |
| 17 | CAMKK2 | 1.97472154 |
| 18 | MAPK13 | 1.93185209 |
| 19 | MAPKAPK5 | 1.85339119 |
| 20 | RIPK4 | 1.85021287 |
| 21 | SIK3 | 1.80278155 |
| 22 | TBK1 | 1.80095889 |
| 23 | ARAF | 1.79599413 |
| 24 | STK16 | 1.78374588 |
| 25 | TAOK1 | 1.78035565 |
| 26 | EPHB1 | 1.77228560 |
| 27 | OXSR1 | 1.76362360 |
| 28 | PRPF4B | 1.74457920 |
| 29 | SIK1 | 1.74156942 |
| 30 | TESK2 | 1.66538526 |
| 31 | ZAP70 | 1.64353958 |
| 32 | TYK2 | 1.64151725 |
| 33 | CCNB1 | 1.54613558 |
| 34 | TXK | 1.53129142 |
| 35 | MAP2K4 | 1.49576974 |
| 36 | MINK1 | 1.46966795 |
| 37 | TRIB3 | 1.46864133 |
| 38 | IKBKE | 1.46725837 |
| 39 | BCKDK | 1.40842067 |
| 40 | MAP2K3 | 1.37185807 |
| 41 | STK39 | 1.35963049 |
| 42 | MAP3K9 | 1.33735065 |
| 43 | TESK1 | 1.33144081 |
| 44 | DAPK1 | 1.31412446 |
| 45 | MAP3K6 | 1.30090697 |
| 46 | FES | 1.28798046 |
| 47 | ADRBK2 | 1.24570273 |
| 48 | NME1 | 1.23469853 |
| 49 | BMPR2 | 1.21651706 |
| 50 | MAPK15 | 1.20403345 |
| 51 | BTK | 1.19835618 |
| 52 | HIPK2 | 1.19385918 |
| 53 | DAPK2 | 1.17555506 |
| 54 | KIT | 1.16527224 |
| 55 | CDK8 | 1.14644443 |
| 56 | GRK5 | 1.13852837 |
| 57 | TAOK3 | 1.12112616 |
| 58 | BRAF | 1.08916910 |
| 59 | CSK | 1.08448381 |
| 60 | NTRK2 | 1.07982659 |
| 61 | EPHA3 | 1.07331860 |
| 62 | CAMK2A | 1.06648764 |
| 63 | CSF1R | 1.05101172 |
| 64 | JAK3 | 1.04762606 |
| 65 | MYLK | 1.04434404 |
| 66 | PTK2B | 1.01961762 |
| 67 | CAMK2B | 0.97505975 |
| 68 | PAK6 | 0.96714114 |
| 69 | HCK | 0.94440218 |
| 70 | PRKCG | 0.94092561 |
| 71 | PRKD2 | 0.93022361 |
| 72 | CDK3 | 0.92866677 |
| 73 | GRK7 | 0.92213314 |
| 74 | MAP4K2 | 0.89062237 |
| 75 | DYRK1B | 0.88796713 |
| 76 | RPS6KA2 | 0.88685425 |
| 77 | ITK | 0.88578625 |
| 78 | NTRK1 | 0.87963087 |
| 79 | PNCK | 0.87373040 |
| 80 | CAMK1 | 0.86202024 |
| 81 | JAK1 | 0.85108911 |
| 82 | LCK | 0.84504804 |
| 83 | CDC42BPA | 0.84148812 |
| 84 | FLT3 | 0.81967931 |
| 85 | BMPR1B | 0.81877279 |
| 86 | KSR2 | 0.79726472 |
| 87 | MAP3K3 | 0.77719495 |
| 88 | PDK1 | 0.76570414 |
| 89 | MATK | 0.76503463 |
| 90 | PDK3 | 0.76481303 |
| 91 | PDK4 | 0.76481303 |
| 92 | PLK2 | 0.75607088 |
| 93 | MAPK7 | 0.75542115 |
| 94 | PIM2 | 0.74553976 |
| 95 | CDK5 | 0.73622268 |
| 96 | JAK2 | 0.73462808 |
| 97 | WNK4 | 0.72671395 |
| 98 | WNK3 | 0.72143884 |
| 99 | RAF1 | 0.70652284 |
| 100 | STK38 | 0.70318074 |
| 101 | IKBKB | 0.69481979 |
| 102 | PDPK1 | 0.68822068 |
| 103 | MAP2K6 | 0.66951461 |
| 104 | BRSK2 | 0.65900287 |
| 105 | IRAK1 | 0.65794639 |
| 106 | KDR | 0.64493573 |
| 107 | PHKG2 | 0.64113188 |
| 108 | PHKG1 | 0.64113188 |
| 109 | NEK6 | 0.63008879 |
| 110 | FYN | 0.62785829 |
| 111 | PRKD1 | 0.62622139 |
| 112 | RPS6KC1 | 0.62127777 |
| 113 | RPS6KL1 | 0.62127777 |
| 114 | SGK494 | 0.61949451 |
| 115 | SGK223 | 0.61949451 |
| 116 | PRKCE | 0.61880105 |
| 117 | MARK3 | 0.61877721 |
| 118 | MAP3K7 | 0.60600531 |
| 119 | BCR | 0.60436141 |
| 120 | TNK2 | 0.58086279 |
| 121 | UHMK1 | 0.57899074 |
| 122 | RPS6KA6 | 0.57818127 |
| 123 | PRKCH | 0.57682976 |
| 124 | SGK2 | 0.56423950 |
| 125 | CAMK2D | 0.55011601 |
| 126 | MAP2K2 | 0.54957992 |
| 127 | CDK18 | 0.54626908 |
| 128 | PINK1 | 0.54507479 |
| 129 | DYRK1A | 0.52922431 |
| 130 | IRAK2 | 0.52839250 |
| 131 | PRKCZ | 0.52520174 |
| 132 | CDK15 | 0.51403913 |
| 133 | CAMK2G | 0.51278305 |
| 134 | TEC | 0.51049990 |
| 135 | ADRBK1 | 0.49417731 |
| 136 | CDK11A | 0.48943871 |
| 137 | SIK2 | 0.48916086 |
| 138 | MAPK4 | 0.48223598 |
| 139 | SYK | 0.47684708 |
| 140 | MARK2 | 0.47539234 |
| 141 | CDK14 | 0.46448306 |
| 142 | TAOK2 | 0.46352340 |
| 143 | MARK1 | 0.44636922 |
| 144 | CAMKK1 | 0.44328335 |
| 145 | PKN1 | 0.43414847 |
| 146 | MAP3K14 | 0.42965503 |
| 147 | PTK6 | 0.42660705 |
| 148 | BRD4 | 0.41598845 |
| 149 | CSNK1G2 | 0.41280194 |
| 150 | IRAK4 | 0.40774750 |
| 151 | TLK1 | 0.40688776 |
| 152 | PRKCQ | 0.40187858 |
| 153 | PRKG2 | 0.40183078 |
| 154 | MAP3K1 | 0.39203210 |
| 155 | MAPK12 | 0.39007989 |
| 156 | CHUK | 0.38920627 |
| 157 | MST4 | 0.38374991 |
| 158 | PKN2 | 0.38301792 |
| 159 | FGR | 0.37259812 |
| 160 | LYN | 0.36898533 |
| 161 | CAMK4 | 0.35158258 |
| 162 | PRKACA | 0.34552511 |
| 163 | CSNK1G3 | 0.33979866 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 4.21016009 |
| 2 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.28219825 |
| 3 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.84330610 |
| 4 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.76270782 |
| 5 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.69113235 |
| 6 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.47431063 |
| 7 | Morphine addiction_Homo sapiens_hsa05032 | 2.44489477 |
| 8 | Parkinsons disease_Homo sapiens_hsa05012 | 2.43639022 |
| 9 | GABAergic synapse_Homo sapiens_hsa04727 | 2.40636678 |
| 10 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.39489589 |
| 11 | Olfactory transduction_Homo sapiens_hsa04740 | 2.21632514 |
| 12 | Circadian entrainment_Homo sapiens_hsa04713 | 2.21412776 |
| 13 | Long-term potentiation_Homo sapiens_hsa04720 | 2.15683553 |
| 14 | Alzheimers disease_Homo sapiens_hsa05010 | 2.15519088 |
| 15 | Allograft rejection_Homo sapiens_hsa05330 | 2.10230807 |
| 16 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.01277686 |
| 17 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.96181115 |
| 18 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.95818123 |
| 19 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.95520201 |
| 20 | Taste transduction_Homo sapiens_hsa04742 | 1.93694313 |
| 21 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.90979486 |
| 22 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.88967746 |
| 23 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.84488394 |
| 24 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.82414330 |
| 25 | Leishmaniasis_Homo sapiens_hsa05140 | 1.77772522 |
| 26 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.76579057 |
| 27 | Huntingtons disease_Homo sapiens_hsa05016 | 1.75681125 |
| 28 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.69357397 |
| 29 | Salivary secretion_Homo sapiens_hsa04970 | 1.61115855 |
| 30 | Protein export_Homo sapiens_hsa03060 | 1.59220516 |
| 31 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.56683138 |
| 32 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.56160991 |
| 33 | Long-term depression_Homo sapiens_hsa04730 | 1.54487426 |
| 34 | Insulin secretion_Homo sapiens_hsa04911 | 1.50715135 |
| 35 | Tuberculosis_Homo sapiens_hsa05152 | 1.49875296 |
| 36 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.46908060 |
| 37 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.46627449 |
| 38 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.42989716 |
| 39 | Asthma_Homo sapiens_hsa05310 | 1.40556564 |
| 40 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.39516217 |
| 41 | Renin secretion_Homo sapiens_hsa04924 | 1.37249282 |
| 42 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.32299557 |
| 43 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.32008261 |
| 44 | Cocaine addiction_Homo sapiens_hsa05030 | 1.26072337 |
| 45 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.25811091 |
| 46 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.25556850 |
| 47 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.20863222 |
| 48 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.16462436 |
| 49 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.16448911 |
| 50 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.16342846 |
| 51 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.16003634 |
| 52 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.14996550 |
| 53 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.14730946 |
| 54 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.13281247 |
| 55 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.10633049 |
| 56 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.09531159 |
| 57 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.07977762 |
| 58 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.06088665 |
| 59 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.04808299 |
| 60 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.04148446 |
| 61 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.03608045 |
| 62 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.03515685 |
| 63 | Other glycan degradation_Homo sapiens_hsa00511 | 1.02600228 |
| 64 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.01423926 |
| 65 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.01346471 |
| 66 | Pertussis_Homo sapiens_hsa05133 | 1.00243698 |
| 67 | Viral myocarditis_Homo sapiens_hsa05416 | 0.99337570 |
| 68 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.99234755 |
| 69 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.99203217 |
| 70 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.99076849 |
| 71 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.98010742 |
| 72 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.94643938 |
| 73 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.94009657 |
| 74 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.93224437 |
| 75 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.92821989 |
| 76 | Endocytosis_Homo sapiens_hsa04144 | 0.89787115 |
| 77 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.89224477 |
| 78 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.88822208 |
| 79 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.88753721 |
| 80 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.87878420 |
| 81 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.87785500 |
| 82 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.87253731 |
| 83 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.86746253 |
| 84 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.83412995 |
| 85 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.81634102 |
| 86 | Malaria_Homo sapiens_hsa05144 | 0.81569286 |
| 87 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.81134694 |
| 88 | Influenza A_Homo sapiens_hsa05164 | 0.80791621 |
| 89 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.80688558 |
| 90 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.80368023 |
| 91 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.80154282 |
| 92 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.80073664 |
| 93 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.78989334 |
| 94 | ABC transporters_Homo sapiens_hsa02010 | 0.78567220 |
| 95 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.76225081 |
| 96 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.76117650 |
| 97 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.75950767 |
| 98 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.74223927 |
| 99 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.73597386 |
| 100 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.72649872 |
| 101 | Salmonella infection_Homo sapiens_hsa05132 | 0.71600685 |
| 102 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.71438322 |
| 103 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.71266280 |
| 104 | Platelet activation_Homo sapiens_hsa04611 | 0.70771355 |
| 105 | Gap junction_Homo sapiens_hsa04540 | 0.67818631 |
| 106 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.66688178 |
| 107 | Measles_Homo sapiens_hsa05162 | 0.66162224 |
| 108 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.65700167 |
| 109 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.64732128 |
| 110 | Hepatitis C_Homo sapiens_hsa05160 | 0.64067597 |
| 111 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.63020786 |
| 112 | Phagosome_Homo sapiens_hsa04145 | 0.61981993 |
| 113 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.61764387 |
| 114 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.57604463 |
| 115 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.57251140 |
| 116 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.56047880 |
| 117 | Lysosome_Homo sapiens_hsa04142 | 0.54981525 |
| 118 | Proteasome_Homo sapiens_hsa03050 | 0.54944906 |
| 119 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.54564747 |
| 120 | Ribosome_Homo sapiens_hsa03010 | 0.53974117 |
| 121 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.53181785 |
| 122 | Circadian rhythm_Homo sapiens_hsa04710 | 0.52935760 |
| 123 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.52450186 |
| 124 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.52323394 |
| 125 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.52177264 |
| 126 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.52172122 |
| 127 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.51566527 |
| 128 | Purine metabolism_Homo sapiens_hsa00230 | 0.50315403 |
| 129 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.49722199 |
| 130 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.48531886 |
| 131 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.47637404 |
| 132 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.47339403 |
| 133 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.46106137 |
| 134 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.43625671 |
| 135 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.43066897 |
| 136 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.42910645 |
| 137 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.40518361 |
| 138 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.38970953 |
| 139 | Metabolic pathways_Homo sapiens_hsa01100 | 0.38945271 |
| 140 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.38729656 |
| 141 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.38688853 |
| 142 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.38529987 |
| 143 | Phototransduction_Homo sapiens_hsa04744 | 0.37478334 |
| 144 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.35479803 |
| 145 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.34518201 |
| 146 | Melanogenesis_Homo sapiens_hsa04916 | 0.32182785 |
| 147 | RNA polymerase_Homo sapiens_hsa03020 | 0.31932374 |
| 148 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.29791784 |
| 149 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.28472548 |
| 150 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.26707717 |
| 151 | Axon guidance_Homo sapiens_hsa04360 | 0.24848713 |
| 152 | Shigellosis_Homo sapiens_hsa05131 | 0.24079036 |
| 153 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.23417901 |
| 154 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.22806910 |

